Correlation Between Diamyd Medical and CANON MARKETING

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and CANON MARKETING at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and CANON MARKETING into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diamyd Medical AB and CANON MARKETING JP, you can compare the effects of market volatilities on Diamyd Medical and CANON MARKETING and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of CANON MARKETING. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and CANON MARKETING.

Diversification Opportunities for Diamyd Medical and CANON MARKETING

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Diamyd and CANON is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and CANON MARKETING JP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CANON MARKETING JP and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with CANON MARKETING. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CANON MARKETING JP has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and CANON MARKETING go up and down completely randomly.

Pair Corralation between Diamyd Medical and CANON MARKETING

Assuming the 90 days horizon Diamyd Medical AB is expected to under-perform the CANON MARKETING. In addition to that, Diamyd Medical is 2.82 times more volatile than CANON MARKETING JP. It trades about -0.13 of its total potential returns per unit of risk. CANON MARKETING JP is currently generating about 0.44 per unit of volatility. If you would invest  2,620  in CANON MARKETING JP on August 25, 2024 and sell it today you would earn a total of  300.00  from holding CANON MARKETING JP or generate 11.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Diamyd Medical AB  vs.  CANON MARKETING JP

 Performance 
       Timeline  
Diamyd Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Diamyd Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
CANON MARKETING JP 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CANON MARKETING JP are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable forward-looking indicators, CANON MARKETING is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Diamyd Medical and CANON MARKETING Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Diamyd Medical and CANON MARKETING

The main advantage of trading using opposite Diamyd Medical and CANON MARKETING positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, CANON MARKETING can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CANON MARKETING will offset losses from the drop in CANON MARKETING's long position.
The idea behind Diamyd Medical AB and CANON MARKETING JP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance